A Randomized Controlled Study on the Waveform Periodicity Analysis of Complex Fractionated Electrograms in Patients With Persistent Atrial Fibrillation

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Atrial fibrillation (AF) has been the most frequently occurring, sustained arrhythmia, which causes significant morbidity and mortality. AF may not always be a totally random process. It can be maintained by stable and rapid reentrant circuits resulting in fibrillary conduction throughout the atria. During mapping of AF, difficulty is frequently encountered during the identification of culprit sites and an analysis of the wave propagation particularly when the electrogram signals demonstrate wide temporal and spatial disparities. Catheter ablation targeting regions with fractionated potentials or high frequencies during AF, has been previously proposed as a treatment strategy. However, the benefit of adjunctive CFAE (complex fractionated atrial electrogram) ablation or linear ablation after successful PVI (pulmonary vein isolation) was controversial based on the recent data from the Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial Part II (STAR AF II) trial. Therefore, the optimal ablation strategy for persistent AF remains undetermined and an alternative approach has to be explored.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 90
Healthy Volunteers: f
View:

• Patents who sign the informed consent forms, and allow to be followed.

• Symptomatic AF refractory or intolerant to at least one Class 1 or 3 antiarrhythmic medication.

• Patients with persistent/permanent AF (sustained beyond seven days, or lasting less than seven days but necessitating pharmacologic or electrical cardioversion).

• Patients with age equal or greater than 20 years old regardless of gender.

Locations
Other Locations
Taiwan
Taipei General Veterans Hospital
RECRUITING
Taipei
Contact Information
Primary
Chia-Hsin Chiang
qqsnoopy0223@gmail.com
+886-2-28712121
Time Frame
Start Date: 2019-02-19
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 80
Treatments
Experimental: Pulmonary vein isolation + Waveform Periodicity Group
Pulmonary vein isolation + Substrate ablation
Other: Pulmonary vein isolation group
Pulmonary vein isolation (Conventional treatment)
Related Therapeutic Areas
Sponsors
Leads: Taipei Veterans General Hospital, Taiwan

This content was sourced from clinicaltrials.gov